The SITC Annual Meeting is supported in part by grants from 7 Hills Pharma, LLC, AbbVie, Inc., Amgen, AstraZeneca Pharmaceuticals LP, Bayer Healthcare Pharmaceuticals U.S., Bristol-Myers Squibb, Celgene Corporation, Celldex Therapeutics, Inc., Dendreon Pharmaceuticals North America LLC, Fluidigm, Genentech, HalioDx, Idera Pharmaceuticals, Incyte Corporation, Janssen Research & Development, LLC, Kite Pharma, Inc., Merck & Co., Inc., NanoString Technologies, Novartis, Novartis Pharmaceuticals Corporation, The Parker Institute for Cancer Immunotherapy, Pfizer, Inc., and Prometheus Laboratories Inc., and Regeneron Pharmaceuticals, Inc.